Cancer is on the rise worldwide: according to the World Health Organization, there will be over 35 million Read More
Merck buys B-cell therapy drug from Curon Biopharmaceutical for $700 million
Radiation doses from computed tomography (CT) scans on patients are variable across patients and hospitals; those radiation doses Read More
Swiss pharmaceutical company Galderma, which specializes in dermatological treatments and skin care products, was formed in 1981 by L’Oréal and Nestlé Read More
Cell engineering is the process of adding, deleting, or modifying genetic sequences in living cells, including altering cell Read More
Immune checkpoint blockade (ICB) is a treatment for cancer that involves the use of drugs, called immune checkpoint inhibitors Read More
Flagship Pioneering is a biotechnology company that creates and funds bioplatform companies; since its founded in 2000, it Read More
As we’ve previously written about, edtech is surging in the Middle East and North Africa (MENA) region: funding for Read More
Third Arc Bio is a company that says its on mission to deliver transformational therapies for solid tumors and inflammatory Read More
Artificial intelligence is touching literally every industry right now, from healthcare to logistics to eductation: globally, the AI Read More
India spent just 3.28% of its GDP on healthcare in 2021, one of the lowest in the world; Japan, for Read More
The Middle East and North Africa (MENA) region has seen a big rise in edtech funding in recent Read More
In 2022, the Environment Agency – Abu Dhabi (EAD) launched the Abu Dhabi Environmental Centennial 2071, which it called, “a Read More
While edtech funding has certainly slowed in recent years, there’s still a lot of opportunity, and not just Read More
Is healthtech investing finally back? It’s been a rough few years for digital health investing: once the pandemic receded, Read More
Primary care is the gateway for healthcare, serving as the entry point for how most people receive their Read More